Kimura’s disease has a high survival rate and does not affect survival if it is treated aggressively and effectively. Kimura’s disease, also known as eosinophilic lymphogranulomatosis, is a rare disease with an undetermined etiology. The lesions are mainly deep in the subcutaneous area, invading the dermis and muscles, and there is also proliferation and infiltration of inflammatory cells. The pathogenesis of Kimura’s disease has a certain age limit, clinically, the onset of this disease is about 38-72 years old, will affect the health of life, the average life expectancy is about 75 years. However, if treatment is actively pursued, patients can also achieve a relatively long survival period that does not even affect life expectancy. It is recommended that if a patient is diagnosed with Kimura’s disease, he or she should actively undergo regular treatment. Currently, the main treatment methods include drug therapy and radiation therapy, and early treatment is not only conducive to improving the quality of life of the patient, reducing pain, but also prolonging the survival time.